Elevated free secretory component in early rheumatoid arthritis and prior to arthritis development in patients at increased risk
- PMID: 31504979
- PMCID: PMC7850007
- DOI: 10.1093/rheumatology/kez348
Elevated free secretory component in early rheumatoid arthritis and prior to arthritis development in patients at increased risk
Abstract
Objectives: Considering growing evidence of mucosal involvement in RA induction, this study investigated circulating free secretory component (SC) in patients with either recent-onset RA or with ACPA and musculoskeletal pain.
Methods: Two prospective cohorts were studied: TIRA-2 comprising 452 recent-onset RA patients with 3 years of clinical and radiological follow-up, and TIRx patients (n = 104) with ACPA IgG and musculoskeletal pain followed for 290 weeks (median). Blood donors and three different chronic inflammatory diseases served as controls. Free SC was analysed by sandwich ELISA.
Results: Serum levels of free SC were significantly higher in TIRA-2 patients compared with TIRx and all control groups (P < 0.01). Among TIRx patients who subsequently developed arthritis, free SC levels were higher compared with all control groups (P < 0.05) except ankylosing spondylitis (P = 0.74). In TIRA-2, patients with ACPA had higher baseline levels of free SC compared with ACPA negative patients (P < 0.001). Free SC status at baseline did not predict radiographic joint damage or disease activity over time. In TIRx, elevated free SC at baseline trendwise associated with arthritis development during follow-up (P = 0.066) but this disappeared when adjusting for confounders (P = 0.72). Cigarette smoking was associated with higher levels of free SC in both cohorts.
Conclusion: Serum free SC levels are increased in recent-onset RA compared with other inflammatory diseases, and associate with ACPA and smoking. Free SC is elevated before arthritis development among ACPA positive patients with musculoskeletal pain, but does not predict arthritis development. These findings support mucosal engagement in RA development.
Keywords: clinical progress; cyclic citrullinated peptide antibodies (ACPA); free secretory component; musculoskeletal pain; rheumatoid arthritis (RA).
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology.
Figures



Similar articles
-
Circulating secretory component-containing anti-citrullinated protein antibodies prior to symptom onset in rheumatoid arthritis.Rheumatology (Oxford). 2025 May 1;64(5):3166-3170. doi: 10.1093/rheumatology/keaf032. Rheumatology (Oxford). 2025. PMID: 39836631 Free PMC article.
-
Circulating anti-citrullinated protein antibodies containing secretory component are prognostic for arthritis onset in at-risk patients.Clin Exp Immunol. 2021 Jun;204(3):344-351. doi: 10.1111/cei.13591. Epub 2021 Mar 24. Clin Exp Immunol. 2021. PMID: 33675063 Free PMC article.
-
Secretory anti-citrullinated protein antibodies in serum associate with lung involvement in early rheumatoid arthritis.Rheumatology (Oxford). 2020 Apr 1;59(4):852-859. doi: 10.1093/rheumatology/kez377. Rheumatology (Oxford). 2020. PMID: 31504962 Free PMC article.
-
Clinical presentation and treatment response in ACPA-negative rheumatoid arthritis.Joint Bone Spine. 2025 Mar;92(2):105823. doi: 10.1016/j.jbspin.2024.105823. Epub 2024 Nov 20. Joint Bone Spine. 2025. PMID: 39577740 Review.
-
Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction.Nat Rev Rheumatol. 2018 Sep;14(9):542-557. doi: 10.1038/s41584-018-0070-0. Nat Rev Rheumatol. 2018. PMID: 30111803 Free PMC article. Review.
Cited by
-
Inhalant and Additional Mucosal-Related Environmental Risks for Rheumatoid Arthritis.Rheum Dis Clin North Am. 2022 Nov;48(4):781-798. doi: 10.1016/j.rdc.2022.06.002. Rheum Dis Clin North Am. 2022. PMID: 36332995 Free PMC article. Review.
-
Antibodies to leukotoxin A from the periodontal pathogen Aggregatibacter actinomycetemcomitans in patients at an increased risk of rheumatoid arthritis.Front Med (Lausanne). 2023 Aug 3;10:1176165. doi: 10.3389/fmed.2023.1176165. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37601773 Free PMC article.
-
Presence of salivary IgA anti-citrullinated protein antibodies associate with higher disease activity in patients with rheumatoid arthritis.Arthritis Res Ther. 2020 Nov 23;22(1):274. doi: 10.1186/s13075-020-02363-0. Arthritis Res Ther. 2020. PMID: 33225988 Free PMC article.
-
Windows for intervention in the prearthritis phase of rheumatoid arthritis? A narrative review of key triggering events and potential preventive strategies.RMD Open. 2025 Jul 10;11(3):e005778. doi: 10.1136/rmdopen-2025-005778. RMD Open. 2025. PMID: 40639878 Free PMC article. Review.
-
Exhaled Nitric Oxide Reflects the Immune Reactions of the Airways in Early Rheumatoid Arthritis.Biomedicines. 2024 Apr 26;12(5):964. doi: 10.3390/biomedicines12050964. Biomedicines. 2024. PMID: 38790926 Free PMC article.
References
-
- Klareskog L, Malmstrom V, Lundberg K, Padyukov L, Alfredsson L.. Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Semin Immunol 2011;23:92–8. - PubMed
-
- van de Sande MG, de Hair MJ, van der Leij C. et al. Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase. Ann Rheum Dis 2011;70:772–7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials